Suchergebnisse - "Lenalidomide"

PubPharm (5.975)

41

New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma

enthalten in: Hematology/oncology clinics of North America | 2024

von Abdallah, N. | Kumar, S.

42

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma : A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Oriol, A. | Dimopoulos, M. | Schjesvold, F. | +12

43

Lenalidomide, rituximab (R2), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma

enthalten in: Leukemia & lymphoma | 2024

von Hill, B. | Chen, Y. | Jagadeesh, D. | +7

44

Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma

enthalten in: Annals of hematology | 2024

von Duan, H. | Jiang, Q. | Liu, L. | +6

45

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

enthalten in: JAMA network open | 2024

von Peipert, J. | Zhao, F. | Lee, J. | +14

46

A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma

enthalten in: Haematologica | 2024

von Fehniger, T. | Watkins, M. | Ezenwajiaku, N. | +14

47

A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia : Results from the LI-1 trial

enthalten in: British journal of haematology | 2024

von Copland, M. | Ariti, C. | Thomas, I. | +10

48

Smoldering Multiple Myeloma : Observation Versus Control Versus Cure

enthalten in: Hematology/oncology clinics of North America | 2024

von Rajkumar, S. | Bergsagel, P. | Kumar, S.

49

Metformin and chidamide synergistically suppress multiple myeloma progression and enhance lenalidomide/bortezomib sensitivity

enthalten in: Environmental toxicology | 2024

von Mao, J. | Chen, R. | Xue, L. | +3

50

Cereblon-Targeting Ligase Degraders in Myeloma : Mechanisms of Action and Resistance

enthalten in: Hematology/oncology clinics of North America | 2024

von Lee, H. | Neri, P. | Bahlis, N.